semaglutide news october 16 2025 Compound versions of GLP-1 drugs for weight loss halted by FDA semaglutide news october 16 2025

medRxiv Preprint, 2025

NICE TA664 recommends liraglutide 3.0 mg for weight management under similar specialist service criteria to semaglutide, though it typically produces slightly less weight reduction (approximately 810% of initial body weight)

The actions of agouti-related peptide (AgRP) neurons and pro-opiomelanocortin (POMC) neurons in the arcuate nucleus (ARC), the most renowned cell types of the hypothalamus governing homeostatic actions and inducing hunger, were previously understood to be mainly regulated by internal nutritional status or hormones such as leptin or ghrelin [45]

and we dont need to make any changes from the initial dosing to the higher dosing. Dr

In California, 503A compounding pharmacies may only prepare GLP-1 medications when a patient has an intolerance to FDA-approved versions like Wegovy , Ozempic , Zepbound , or Mounjaro